You just read:

BioMarin Announces Ongoing Study Demonstrates Durable Treatment Benefit from Brineura® (cerliponase alfa) for 3 Years

News provided by

BioMarin Pharmaceutical Inc.

Feb 07, 2019, 16:28 ET